World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
83
Citations
24190
World Ranking
1451
National Ranking
734

Stuart M. Levitz publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Stuart M. Levitz sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 220 publications — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Stuart M. Levitz D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Stuart M. Levitz sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 83 D-Index — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2012 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Stuart M. Levitz is affiliated with the University of Massachusetts Chan Medical School in the United States. Their research focuses primarily on the field of Medicine, with substantial work in Epidemiology and Infectious Diseases. Additional attention has been directed toward Plant Science, Immunology, and Molecular Biology within their scholarly contributions.

The main topics covered in Levitz's work include:

  • Fungal Infections and Studies
  • Antifungal resistance and susceptibility
  • Nail Diseases and Treatments
  • Plant-Microbe Interactions and Immunity
  • Asthma and respiratory diseases
  • Antimicrobial Peptides and Activities
  • Plant Pathogens and Fungal Diseases

Levitz has published several papers in various scientific journals, some of which include:

  • Vaccines for human fungal diseases: close but still a long way to go (2021) in npj Vaccines
  • The "Black Fungus" in India: The Emerging Syndemic of COVID-19-Associated Mucormycosis (2021) in Annals of Internal Medicine
  • Candida auris outbreak involving liver transplant recipients in a surgical intensive care unit (2020) in American Journal of Transplantation
  • Cryptococcus neoformans Cda1 and Cda2 coordinate deacetylation of chitin during infection to control fungal virulence (2021) in The Cell Surface
  • Protection of Mice against Experimental Cryptococcosis by Synthesized Peptides Delivered in Glucan Particles (2022) in mBio

Frequent collaborators in their research include:

  • Charles A. Specht
  • Chrono K. Lee
  • Lorena V. N. Oliveira
  • Maureen M. Hester
  • Ruiying Wang

Levitz has published multiple times in specific venues such as:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • mBio
  • PLoS Pathogens
  • npj Vaccines
  • Annals of Internal Medicine

The scope of their work includes 67 publications categorized under Medicine with emphasis on epidemiological and infectious disease aspects. The scientist's research addresses antifungal resistance, mechanisms of fungal pathogenesis, and efforts toward vaccine development among other concerns related to fungal diseases and immune responses.

In recognition of their contributions, Stuart M. Levitz was named a Fellow of the American Association for the Advancement of Science (AAAS) in 2012.

Best Publications

  • Hidden Killers: Human Fungal Infections

    Gordon D. Brown;David W. Denning;Neil A. R. Gow;Stuart M. Levitz

  • Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects on Candida albicans.

    F. G. Oppenheim;Tao Xu;F. M. Mcmillian;S. M. Levitz

  • Tackling human fungal infections.

    Gordon D. Brown;David W. Denning;Stuart M. Levitz

  • The Contribution of the Toll-Like/IL-1 Receptor Superfamily to Innate and Adaptive Immunity to Fungal Pathogens In Vivo

    Silvia Bellocchio;Claudia Montagnoli;Silvia Bozza;Roberta Gaziano

  • The Ecology of Cryptococcus neoformans and the Epidemiology of Cryptococcosis

    Stuart M. Levitz

  • The immune response to fungal infections

    Shmuel Shoham;Stuart M. Levitz

  • Toll-like receptor 4 mediates intracellular signaling without TNF-alpha release in response to Cryptococcus neoformans polysaccharide capsule.

    Shmuel Shoham;Chao Huang;Jian-Min Chen;Douglas T. Golenbock

  • The Case for Adopting the "Species Complex" Nomenclature for the Etiologic Agents of Cryptococcosis.

    Kyung J. Kwon-Chung;John E. Bennett;Brian L. Wickes;Wieland Meyer

  • Toll-like receptor (TLR) signaling in response to Aspergillus fumigatus.

    Salamatu S. Mambula;Keya Sau;Philipp Henneke;Douglas T. Golenbock

  • Virulence factors of medically important fungi.

    L H Hogan;B S Klein;S M Levitz

  • Anticandidal activity of major human salivary histatins.

    Tao Xu;S. M. Levitz;R. D. Diamond;F. G. Oppenheim

  • Cryptococcus neoformans Resides in an Acidic Phagolysosome of Human Macrophages

    Stuart M. Levitz;Shu Hua Nong;Kurt F. Seetoo;Thomas S. Harrison

  • In vivo bronchoalveolar macrophage defense against Rhizopus oryzae and Aspergillus fumigatus

    Alayn R. Waldorf;Stuart M. Levitz;Richard D. Diamond

  • A Rapid Colorimetric Assay of Fungal Viability with the Tetrazolium Salt MTT

    Stuart M. Levitz;Richard D. Diamond

  • A chitin synthase and its regulator protein are critical for chitosan production and growth of the fungal pathogen Cryptococcus neoformans.

    Isaac R. Banks;Charles A. Specht;Maureen J. Donlin;Kimberly J. Gerik

  • The Antifungal Drug Amphotericin B Promotes Inflammatory Cytokine Release by a Toll-like Receptor- and CD14-dependent Mechanism

    Keya Sau;Salamatu S. Mambula;Eicke Latz;Philipp Henneke

  • Idiopathic CD4+ T-Lymphocytopenia -- Four Patients with Opportunistic Infections and No Evidence of HIV Infection

    Robert A. Duncan;C. Fordham von Reyn;George M. Alliegro;Zahra Toossi

  • Chitosan but Not Chitin Activates the Inflammasome by a Mechanism Dependent upon Phagocytosis

    Chelsea L. Bueter;Chrono K. Lee;Vijay A.K. Rathinam;Gloria J. Healy

  • Innate sensing of chitin and chitosan

    Chelsea L. Bueter;Charles A. Specht;Stuart M. Levitz

  • Involvement of CD14, toll-like receptors 2 and 4, and MyD88 in the host response to the fungal pathogen Cryptococcus neoformans in vivo.

    Lauren E. Yauch;Michael K. Mansour;Shmuel Shoham;James B. Rottman

  • A Simplified New Assay for Assessment of Fungal Cell Damage with the Tetrazolium Dye, (2,3)-bis-(2-Methoxy-4-Nitro-5-Sulphenyl)-(2H)-Tetrazolium-5-Carboxanilide (XTT)

    Tova Meshulam;Stuart M. Levitz;Laurent Christin;Richard D. Diamond

  • In Vitro Killing of Spores and Hyphae of Aspergillus fumigatus and Rhizopus oryzae by Rabbit Neutrophil Cationic Peptides and Bronchoalveolar Macrophages

    Stuart M. Levitz;Michael E. Selsted;Tomas Ganz;Robert I. Lehrer

  • IMMUNE RESPONSE TO FUNGAL INFECTIONS

    S Shoham;S M Levitz

Frequent Co-Authors

Charles A. Specht
Charles A. Specht University of Massachusetts Chan Medical School
Richard D. Diamond
Richard D. Diamond Boston Medical Center
Thomas S. Harrison
Thomas S. Harrison St George's, University of London
Douglas T. Golenbock
Douglas T. Golenbock University of Massachusetts Chan Medical School
Jennifer K. Lodge
Jennifer K. Lodge Washington University in St. Louis
Sanjay Ram
Sanjay Ram University of Massachusetts Chan Medical School
Garry T. Cole
Garry T. Cole The University of Texas at San Antonio
Kyung J. Kwon-Chung
Kyung J. Kwon-Chung National Institutes of Health
Robert W. Finberg
Robert W. Finberg University of Massachusetts Chan Medical School
Françoise Dromer
Françoise Dromer Institut Pasteur

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related nursing degrees can open diverse career pathways in healthcare and research. Many professionals choose to enhance their qualifications through accelerated programs that allow quicker entry into clinical roles.

One popular option is pursuing a nurse practitioner accelerated program. These programs cater to individuals with a background in nursing or related fields and prepare them for advanced clinical responsibilities in immunology-related care.

For non-nurses looking to enter the nursing profession, online ABSN programs for non nurses offer flexible and accessible routes to achieve a Bachelor of Science in Nursing. These programs are designed to build foundational nursing skills efficiently.

Similarly, accelerated BSN programs for non nurses provide a fast-track option for career changers aiming to work in immunology labs and patient care settings. These pathways often have less stringent admission requirements, making them accessible to more candidates.

Additionally, for those interested in entry-level nursing roles, there are accredited LPN programs easy to get into. These programs prepare students for licensure as practical nurses, offering a foundational role that supports immunology researchers and clinicians alike.

Best Scientists Citing Stuart M. Levitz

Trending Scientists

Recently Published Articles